BRISTAMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Bristamycin patents expire, and when can generic versions of Bristamycin launch?
Bristamycin is a drug marketed by Bristol and is included in two NDAs.
The generic ingredient in BRISTAMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for BRISTAMYCIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BRISTAMYCIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BRISTAMYCIN
US Patents and Regulatory Information for BRISTAMYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol | BRISTAMYCIN | erythromycin stearate | TABLET;ORAL | 061304-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol | BRISTAMYCIN | erythromycin stearate | TABLET;ORAL | 061887-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |